Rhumbline Advisers Rx Sight, Inc. Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Rx Sight, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 51,436 shares of RXST stock, worth $500,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,436
Previous 58,091
11.46%
Holding current value
$500,472
Previous $755,000
38.81%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RXST
# of Institutions
170Shares Held
32.1MCall Options Held
64.6KPut Options Held
62.9K-
Black Rock Inc. New York, NY2.4MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$21.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$20.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.83MShares$17.8 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.75MShares$17.1 Million0.02% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $269M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...